A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin

Abstract Ribavirin is an inosine monophosphate dehydrogenase inhibitor. Studies suggest ribavirin aerosol could be a safe and efficacious treatment option in the fight against coronaviruses. However, current treatment is long (12-18 h per day, 3-7 days), limiting clinical utility. A reduction in tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter Couroux (Author), Alexandre Brkovic (Author), Jason L. Vittitow (Author), Robert J. Israel (Author), Chinna Pamidi (Author), Jignesh Patel (Author), Maxime Barakat (Author)
Format: Book
Published: Wiley, 2022-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available